GLSI CIK: 1799788

Greenwich LifeSciences, Inc.

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25

Assets

(positive)
Change from FY21 to FY25
millions USD
FY21:
27.2
FY22:
13.5
FY23:
6.99
FY24:
4.09
FY25:
6.18
(positive)
Change from FY21 to FY25
millions USD
FY21:
0.01
FY22:
0.01
FY23:
0.01
FY24:
0.00
FY25:
0
Total assets
Change from FY21 to FY25
millions USD
FY21:
27.2
FY22:
13.5
FY23:
6.99
FY24:
4.09
FY25:
6.18

Liabilities & Equity

(negative)
Change from FY21 to FY25
millions USD
FY21:
0.39
FY22:
0.26
FY23:
0.29
FY24:
3.19
FY25:
5.82
(negative)
millions USD
FY21:
0
FY22:
0
FY23:
0
FY24:
0
FY25:
0
(positive)
Change from FY21 to FY25
millions USD
FY21:
26.8
FY22:
13.2
FY23:
6.70
FY24:
0.91
FY25:
0.35
Total liabilities & equity
Change from FY21 to FY25
millions USD
FY21:
27.2
FY22:
13.5
FY23:
6.99
FY24:
4.09
FY25:
6.18

All amounts in millions USD Data sources:SEC EDGARTwelve Data